EnteroMedics Inc 4
4 · EnteroMedics Inc · Filed Feb 10, 2017
Insider Transaction Report
Form 4
EnteroMedics IncETRM
TETI NICHOLAS
Director
Transactions
- Award
Director Option (Right to Buy)
2017-02-08+40,000→ 40,000 totalExercise: $7.12From: 2017-02-08Exp: 2027-02-08→ Common Stock (40,000 underlying)
Holdings
- 1
Director Option (right to buy)
Exercise: $27730.50From: 2008-05-06Exp: 2018-05-06→ Common Stock (1 underlying) - 11
Director Option (right to buy)
Exercise: $3402.00From: 2010-02-10Exp: 2020-02-10→ Common Stock (11 underlying) - 9
Director Option (right to buy)
Exercise: $2761.50From: 2011-05-05Exp: 2021-05-05→ Common Stock (9 underlying) - 9
Director Option (right to buy)
Exercise: $924.00From: 2013-05-08Exp: 2023-05-08→ Common Stock (9 underlying) - 23
Director Option (right to buy)
Exercise: $1932.00From: 2014-05-07Exp: 2024-05-07→ Common Stock (23 underlying) - 23
Director Option (right to buy)
Exercise: $1176.00From: 2015-05-06Exp: 2025-05-06→ Common Stock (23 underlying) - 42
Director Option (Right to Buy)
Exercise: $52.50From: 2016-05-04Exp: 2026-05-04→ Common Stock (42 underlying) - 10
Common Stock
- 1
Director Option (right to buy)
Exercise: $12159.00From: 2009-05-05Exp: 2019-05-05→ Common Stock (1 underlying) - 4
Director Option (right to buy)
Exercise: $47008.50From: 2007-04-27Exp: 2017-04-27→ Common Stock (4 underlying) - 23
Director Option (right to buy)
Exercise: $14490.00From: 2009-05-28Exp: 2019-05-28→ Common Stock (23 underlying) - 1
Director Option (right to buy)
Exercise: $2646.00From: 2010-05-06Exp: 2020-05-06→ Common Stock (1 underlying) - 9
Director Option (right to buy)
Exercise: $2908.50From: 2012-05-09Exp: 2022-05-09→ Common Stock (9 underlying) - 23
Director Option (right to buy)
Exercise: $1176.00From: 2015-06-06Exp: 2025-05-06→ Common Stock (23 underlying)
Footnotes (4)
- [F1]On December 27, 2016, EnteroMedics Inc. effected a 1-for-70 reverse stock split of its issued and outstanding shares of common stock, par value $0.01 per share, resulting in a proportional decrease in the total shares of common stock beneficially owned by the reporting person. all previously reported exercise prices, option grants and similar instruments convertible into common stock were proportionally adjusted to reflect the reverse split.
- [F2]Fully vested.
- [F3]Vests immediately as to 25% on date noted and thereafter in cumulative installments of 1/36th per month.
- [F4]Vests in cumulative installments of 1/12th per month beginning the date shown.